Causes and treatments of psychosis, a syndrome associated with a variety of mental, behavioural and emotional problems.

Apart from the drugs, some other therapies have proved successful to slow the onset of Alzheimer's symptoms.

Snoezelen® is a therapeutic approach that uses multisensory experiences. It was developed in the Netherlands in the 1970s for people with developmental disabilities.

Since its creation in 1986, the Eating Disorders Program (EDP) has offered specialized clinical services for people 18 years and older who suffer from anorexia nervosa or bulimia nervosa.

The Intellectual Handicap with Psychiatric Comorbidity Program is designed for people aged 18 to 65 who have a moderate to severe intellectual handicap accompanied by a psychiatric disorder.

A multidisciplinary team Ashok Malla, MD, FRCPC, psychiatrist, director, PEPP-Montréal Ridha Joober, MD, PhD, psychiatrist, assistant director, PEPP-Montréal Evangeline Smith, clinical-administrative chief, PEPP-Montréal

The Clinic for Assessment of Youth at Risk (CAYR) is a sub-program of PEPP-Montréal and accepts youth between 14 and 30 years of age who have never experienced a psychotic episode but who show signs of increased risk for developing psychosis.

Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

The Anxiety Disorders Clinic is a superspecialized (third-line) consultation, assessment and treatment service for people between the ages of 18 and 65 who suffer from one or multiple anxiety disorders.

The Depressive and Suicide Disorders Program is a superspecialized (third-line) service for youth and adults who suffer from refractory and/or recurrent major depressive disorder with or without the presence of suicidal behaviour. The program offers cutting-edge treatment for clients and provides support to families to help them interact with the person in difficulty.